tiprankstipranks
Trending News
More News >
Agios Pharma (AGIO)
NASDAQ:AGIO
US Market

Agios Pharma (AGIO) Income Statement

Compare
675 Followers

Agios Pharma Income Statement

Last quarter (Q3 2025), Agios Pharma's total revenue was $12.88M, an increase of 43.69% from the same quarter last year. In Q3, Agios Pharma's net income was $-103.43M. See Agios Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 36.50M$ 26.82M$ 14.24M$ 0.00$ 0.00
Gross Profit
$ 32.33M$ 17.32M$ 12.54M$ -18.78M$ -18.77M
Operating Expenses
$ 458.07M$ 408.81M$ 401.58M$ 359.64M$ 317.14M
Depreciation and Amortization
$ 5.65M$ 6.62M$ 8.56M$ 18.78M$ 18.77M
EBITDA
$ -420.08M$ -384.86M$ -380.48M$ -337.73M$ -310.53M
Operating Income
$ -425.74M$ -391.49M$ -389.05M$ -378.42M$ -335.92M
Other Income/Expenses
$ 1.14B$ 39.40M$ 157.25M$ 21.91M$ 6.61M
Pretax Income
$ 717.97M$ -352.09M$ -231.80M$ -356.51M$ -329.31M
Net Income
$ 673.73M$ -352.09M$ -231.80M$ 1.60B$ -327.37M
Per Share Metrics
Basic EPS
$ 11.86$ -6.33$ -4.23$ -6.36$ -4.74
Diluted EPS
$ 11.64$ -6.33$ -4.23$ -6.36$ -4.74
Weighted Average Shares Outstanding
56.81M 55.65M 54.79M 60.45M 69.00M
Weighted Average Shares Outstanding (Diluted)
57.89M 55.65M 54.79M 60.45M 69.00M
Currency in USD

Agios Pharma Earnings and Revenue History